Clinical Trial

Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients with Chronic Hepatitis B Over a Five-Year Period
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-25.
Trial Details
NCT Number NCT06896630
Lead Sponsor Assiut University
Conditions Tenofovir Disoproxil Fumarate, Renal Function Disorder, Chronic HBV Infection
Enrollment 172 participants
Start Date 2025-04-10
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-04